[About us] Journal 'Cytokines & Inflammation'

197376, -, . . , . 12,

.: (812) 543 52 14, +7 921 984 11 30, +7 921 909 55 49
: (812) 543 52 14
Web: cytokines.ru


Year 2016
Number 1 Number 2

About journal

Current year


Rules for authors

Contact us


Site map

Our partners:
 English language ONAEGO
Site map Contact us

Contents | Next article | Previous article

Journal 'Cytokines & inflammation', 2010, No. 3

Order this issue

Order PDF of this article

Practitioner Advisor

Number 3'2010

Role of CD40 ligand in prediction of cardiovascular complications in patients with ST-elevation acute myocardial infarction and diabetes mellitus

Barbarash O.L., Osokina A.V., Karetnikova V.N., Gruzdeva O.V., Kashtalap V.V., Tavlueva E.V., Kiprina E.S., Nikonorova N.G.,.Zykov M.V, Barbarash L.S.

State educational Institution of high professional education Kemerovo State Medical Academy of Ministry of Health Care, Kemerovo, Russia

The objective of the study was to evaluate the differences between inflammatory processes in MI patients with and without DM in terms of its prognostic implications.

Methods. 104 MI patients were enrolled in the study, among them 52 had DM type 2. There were no significant differences in gender or age between groups. Endpoints, e.g. recurrent cardiovascular events, were registered during 1 year of follow-up. The inflammation markers (CRP, IL-6, fibrinogen, neopterin), including sCD40L, were checked on 10-14th day of MI. Carbohydrate metabolism impairment markers included admission glycemia measurements, fasting glycemia levels on day 10-14 and glycated hemoglobin levels.

Results. DM patients had higher occurrence of recurrent acute coronary events leading to hospitalization during 1 year of follow-up. Patients with DM type 2 and adverse outcome did have higher initial fibrinogen and sCD40L levels compared with favorable outcome patients. It was found that there was a direct correlation between admission hyperglycemia in MI patients with DM, sCD40L concentrations and an adverse outcome during 1 year of follow-up. (Cytokines and Inflammation. 2010. Vol. 9, 3. P. 25-29.)

Keywords: myocardial infarction, inflammation, diabetes mellitus, sCD40L.

Contents | Next article | Previous article

© 2007-2017 Cytokines and inflammation